Arranon and blood creatine phosphokinase increased Patient Reports February 13, 2012
Arranon Side Effects Report #5958085-7
Arranon side effect was reported by a Physician from JAPAN on Nov 14, 2008. Male patient, child 2 years of age, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm and was treated with Arranon. After drug was administered, patient experienced the following side effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis. Arranon dosage: 70ML PER DAY. During the same period patient was treated with ZYLORIC, COTRIM, HYDROCORTISONE, CYLOCIDE, NEO MINOPHAGEN, FUNGUARD. Patient recovered.
Arranon Side Effects Report #6044087-1
Arranon side effect was reported by a Physician from JAPAN on Jan 08, 2009. Male patient, child 2 years of age, weighting 27.34 lb, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm, neoplasm malignant and was treated with Arranon. After drug was administered, patient experienced the following side effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis. Arranon dosage: 650MGM2 PER DAY. During the same period patient was treated with ZYLORIC, COTRIM, HYDROCORTISONE, CYLOCIDE, NEO MINOPHAGEN, ZOFRAN, FLUDARA. Patient recovered.
Arranon Side Effects Report #6085843-3
Arranon side effect was reported by a Physician from JAPAN on Feb 16, 2009. Male patient, child 2 years of age, weighting 27.34 lb, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm, neoplasm malignant and was treated with Arranon. After drug was administered, patient experienced the following side effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis. Arranon dosage: 650MGM2 PER DAY. During the same period patient was treated with ZYLORIC, BAKTAR, HYDROCORTISONE, CYLOCIDE, NEO MINOPHAGEN, ZOFRAN, FLUDARA. Patient recovered.
Arranon Side Effects Report #6122849-X
Arranon side effect was reported by a Physician from JAPAN on Mar 12, 2009. Male patient, child 2 years of age, weighting 27.34 lb, was diagnosed with prophylaxis, antifungal prophylaxis, central nervous system neoplasm, neoplasm malignant and was treated with Arranon. After drug was administered, patient experienced the following side effects: aldolase increased, blood creatine phosphokinase increased, rhabdomyolysis. Arranon dosage: 650MGM2 PER DAY. During the same period patient was treated with ZYLORIC, BAKTAR, HYDROCORTISONE, CYLOCIDE, NEO MINOPHAGEN, ZOFRAN, FLUDARA, IDARUBICIN. Patient recovered.
Arranon and blood creatine phosphokinase increased 